High-Throughput Screening – Products

AMSBIO has introduced further essential tools for SARS-CoV-2 researchers to help decipher the COVID-19 B.1.1.529 variant.

The use of a chromatographic separation technique (such as high pressure liquid chromatography) in line with a mass spectrometer has been the standard approach for quantitative LC-MS analysis since the commercial introduction of mass spectrometers. Electrospray ionization (ESI) is the most common ionization technique used with LC-MS because of its broad compound coverage and ionization efficiency when compared to other approaches like atmospheric pressure chemical ionization (APCI) or matrix assisted laser desorption ionization (MALDI).

Asynt reports how the Process Intensification Group, within the School of Engineering at Newcastle University, UK is using the MultiCell-PLUS High-Pressure Reactor as part of their program of ongoing research to create a new environmentally friendly generation of catalysts for production of biorenewable chemicals.

Biotechnology company Ingenza is excited to report the successful conclusion to its recent six-month project with Johnson Matthey, a specialty chemicals and sustainable technologies supplier.

Octet® BLI platforms are helping accelerate research on Coronavirus by providing:

High-throughput kinetic interaction analysis solutions to rapidly select and characterize vaccine and therapeutic candidates

Efficient workflows for vaccine and biotherapeutic development research

Fast and flexible platform 

Versatile solutions in upstream and downstream vaccine development

Screen more clones in less time with the ClonePix® 2 System’s fully automated workflow. Our users see major improvements both in productivity and overall costs compared to conventional techniques. Now you can reduce your timelines for cell line development by screening 10X more clones in weeks, not months.

While the complexity of organoids remains challenging, technological advances are enabling organoids to be developed and monitored in an automated fashion, so that they can be exploited in high-throughput drug screening assays.

Affibodies are synthetic antigen-binding proteins. They offer many advantages over monoclonal antibodies, including smaller sizes, enhanced thermal stability and rapid refolding capability. These advantages make affibodies an attractive platform for the development of therapeutics, diagnostics and bioimaging technology.

Optibrium Limited has announced the publication of a peer-reviewed study in Applied AI Letters, “Deep Imputation on Large-Scale Drug Discovery Data”.

BioChromato Inc. has developed an enzyme assay product - the RAPID Tube Plate 600 (TP-600) that is helping deliver outstanding results in in vitro metabolic stability studies.